Skip to main content

Bursa Guard N-B-R (Canada)

This page contains information on Bursa Guard N-B-R for veterinary use.
The information provided typically includes the following:
  • Bursa Guard N-B-R Indications
  • Warnings and cautions for Bursa Guard N-B-R
  • Direction and dosage information for Bursa Guard N-B-R

Bursa Guard N-B-R

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Vaccine

Standard & Variant, Mass & Ark Types, Killed Virus

0.5 mL/dose

Bursa Guard N-B-R Indications

This product has been shown to be effective for the vaccination of healthy chickens 12 to 13 and 20 to 21 weeks of age against Newcastle disease and Bronchitis, Mass. and Ark. type, and to healthy breeder chickens 12 to 13 and 20 to 21 weeks of age to provide passive immunity against standard and variant bursal disease and reovirus in offspring. The duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Composition

This product is a suspension of bursal disease, Newcastle disease, and bronchitis viruses and reovirus emulsified in oil. The following strains are utilized:

Bursal - Standard and Variant E

Newcastle - LaSota

Bronchitis - Mass. and Ark.

Reo - 1133, 2408, MSB

Bursal virus origin: Bursal tissue 100%

Newcastle, bronchitis, reovirus origin: Chick embryo 100%

Directions For Use

Warm vaccine to room temperature. Shake well. Inject 0.5 mL intramuscularly using aseptic technique. Vaccinate at 12-13 weeks of age and repeat at 20-21 weeks of age. Birds should be primed with live reovirus, bronchitis and bursal disease vaccines at least 4 weeks prior to the first use of this product.

Bursa Guard N-B-R Caution

Store in the dark between 2-8°C (35-48°F). Do not freeze. Do not vaccinate within 42 days before slaughter. Do not mix with other products, except as specified on the label. Use entire contents when first opened. Inactivate unused contents before disposal. In case of human exposure, contact a physician.

Warning

Humans injected with this vaccine should seek immediate medical attention. Advise medical personnel that the vaccine is an oil emulsion type.

For Veterinary Use Only

Manufactured by: Boehringer Ingelheim Animal Health USA Inc., Gainesville, GA 30501 USA, VLN/PCN 124/12M5.41

Distributed in Canada by: Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

500 mL/1000 doses

2022-2664-02

CPN: 1182090.4

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   1-800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27